Literature DB >> 14640143

The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14640143

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  8 in total

1.  Negative symptoms and the failure to represent the expected reward value of actions: behavioral and computational modeling evidence.

Authors:  James M Gold; James A Waltz; Tatyana M Matveeva; Zuzana Kasanova; Gregory P Strauss; Ellen S Herbener; Anne G E Collins; Michael J Frank
Journal:  Arch Gen Psychiatry       Date:  2012-02

2.  Patterns of clozapine prescribing in a mental health service in New Zealand.

Authors:  Jeff Harrison; Minna Janlöv; Amanda J Wheeler
Journal:  Pharm World Sci       Date:  2010-06-06

Review 3.  Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder.

Authors:  Tracy Swainston Harrison; Lesley J Scott
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 4.  Mortality Risk Associated With Long-acting Injectable Antipsychotics: A Systematic Review and Meta-analyses of Randomized Controlled Trials.

Authors:  Taro Kishi; Shinji Matsunaga; Nakao Iwata
Journal:  Schizophr Bull       Date:  2016-04-16       Impact factor: 9.306

5.  Clinical equivalence of generic clozapine.

Authors:  Daniel J Healy; Stephan Taylor; Mona Goldman; Kris Barry; Frederic Blow; Karen K Milner
Journal:  Community Ment Health J       Date:  2005-08

6.  Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs.

Authors:  Nancy C Andreasen; Marcus Pressler; Peg Nopoulos; Del Miller; Beng-Choon Ho
Journal:  Biol Psychiatry       Date:  2009-11-07       Impact factor: 13.382

7.  A randomized trial of electronic clinical reminders to improve medication laboratory monitoring.

Authors:  Michael E Matheny; Thomas D Sequist; Andrew C Seger; Julie M Fiskio; Michael Sperling; Don Bugbee; David W Bates; Tejal K Gandhi
Journal:  J Am Med Inform Assoc       Date:  2008-04-24       Impact factor: 4.497

8.  How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.

Authors:  Takefumi Suzuki; Hiroyuki Uchida; Koichiro Watanabe; Kensuke Nomura; Hiroyoshi Takeuchi; Masayuki Tomita; Kenichi Tsunoda; Shintaro Nio; Ryoske Den; Hiroshi Manki; Akira Tanabe; Gohei Yagi; Haruo Kashima
Journal:  Psychopharmacology (Berl)       Date:  2007-08-14       Impact factor: 4.530
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.